share_log

港股异动丨科笛涨近13%,CU-30101药品上市许可申请获受理

Gelonghui Finance ·  Jul 30 22:19

格隆汇7月31日|科笛(2487.HK)盘中最高涨近13%至8.81港元,股价创逾2个月新高。消息面上,集团公布,其CU-30101药品上市许可申请获得国家药监局受理。CU-30101为一种用于皮肤表皮手术的局部利多卡因丁卡因复合表皮麻醉乳膏剂。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment